Co Q-10 100 mg

Co Q-10 100 mg

Puritan's Pride4.7 (848 ratings)
Format:Softgel Quantity: 60 Softgel(s) · 60 servings
Goals
$9.74 $0.16 per serving

Product analysis

53 out of 100

Co Q-10 100 mg may support some measures of blood-vessel health, although the evidence is limited. Its unspecified CoQ10 form makes comparisons with particular tested preparations difficult.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The CoQ10 form is not specified. That prevents a confident comparison of its preparation and absorption characteristics.

Ingredient Transparency63

The CoQ10 amount is clearly stated, making serving comparisons straightforward. Its form is omitted, limiting comparisons with specific preparations.

Value For Money60

The CoQ10 has a moderate cost per serving.

Customer Satisfaction80

Customer ratings are very positive. Hundreds of ratings provide a useful view of satisfaction, without proving health benefits.

Product Focus68

The clearest connection is to selected measures of heart and blood-vessel health, with limited evidence. Its normal role in cellular energy does not establish more everyday energy or faster metabolism.

Format
Softgel
Container
60 Softgel(s)
Per serving
$0.16
Customer rating
4.7 · 848 ratings
Report analysis

Goals

Heart Health
Impact
Highest effect
A- Ingredient FitD+ PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 has limited support for selected blood-vessel and blood-pressure measures in adult studies. Its declared active amount permits comparison with ordinary oral CoQ10 evidence without identifying its oxidation state or establishing special delivery benefits. These findings do not establish routine cardiovascular-event prevention or the effects of sustained daily use from a single serving.

How this product is rated for Heart Health

Ingredient fit86

Coenzyme Q-10 provide the included contribution, with partial coverage of the comparison amounts.
Goal fit
Coenzyme Q-10 provide the relevant focus, while the product is also linked to other goals.
Dose adequacy
The included amounts partly cover the saved comparison ranges, which describe exposure rather than proven treatment doses.

Pathways53

The strongest recorded connection is endothelial nitric-oxide function, with partial coverage of the comparison range.
Depth
The strongest recorded connection is endothelial nitric-oxide function, with partial coverage of the comparison range.
Breadth
Endothelial nitric-oxide function reached the coverage threshold; the remaining configured pathways did not.

Evidence98

Coenzyme Q-10 provides the strongest included evidence, within the limits of its studied outcomes and populations.
Evidence strength
Coenzyme Q-10 provides the strongest included evidence, within the limits of its studied outcomes and populations.
Studied preparation
The included preparations were matched to studied material, within the limits of the outcomes and populations studied.

Formulation logic100

No configured ingredient conflict was identified. The included ingredients can stand alone or have their required partner present.
Partner coverage
The included ingredients can stand alone or have their required partner present.
Conflicts
No configured ingredient conflict was identified.
Effective doses
All included ingredients clear the saved minimum amount threshold; this does not guarantee a noticeable clinical benefit.
Study evidence
Longevity
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 at 100 mg supports normal mitochondrial energy production and antioxidant processes. Limited improvements in skin wrinkles and smoothness were reported with a specific water-soluble preparation; those results cannot be assumed for every CoQ10 material or taken as evidence of longer life.

How this product is rated for Longevity

Ingredient fit73

The relevant ingredient gives the formula a clear focus on the reviewed aging-related functions. Ingredient amounts provide a partial match to the saved exposure comparisons.
Goal fit
The relevant ingredient gives the formula a clear focus on the reviewed aging-related functions.
Dose adequacy
Ingredient amounts provide a partial match to the saved exposure comparisons.

Pathways10

The leading mechanism in the saved assessment is mitochondrial energy production. None of the three target mechanisms reaches the saved coverage threshold.
Depth
The leading mechanism in the saved assessment is mitochondrial energy production.
Breadth
None of the three target mechanisms reaches the saved coverage threshold.

Evidence30

Coenzyme Q-10 leads the saved evidence finding; that comparison does not establish longer life. Preparation matching is limited for Coenzyme Q-10.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding; that comparison does not establish longer life.
Studied preparation
Preparation matching is limited for Coenzyme Q-10.

Formulation logic100

The counted ingredients can contribute independently or have their required partner. No configured ingredient conflict was found in the supplied assessment. 1 of 1 counted ingredients reach the saved minimum amount criterion.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was found in the supplied assessment.
Effective doses
1 of 1 counted ingredients reach the saved minimum amount criterion.
Study evidence
Energy
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 has a normal role in mitochondrial energy production and limited preparation-specific fatigue evidence. The unidentified redox form and 100 mg serving limit direct comparison with the reviewed preparations; cellular energy biology alone does not guarantee more perceived energy.

How this product is rated for Energy

Ingredient fit73

The saved assessment identifies 1 relevant ingredients and no other active ingredients; the formula serves 6 goals. The saved amount assessment is limited overall, with unknown amounts contributing no support.
Goal fit
The saved assessment identifies 1 relevant ingredients and no other active ingredients; the formula serves 6 goals.
Dose adequacy
The saved amount assessment is limited overall, with unknown amounts contributing no support.

Pathways8

Mitochondrial energy production is the strongest represented mechanism, with partial coverage in the saved findings. 0 of the three mechanism targets meets the saved coverage threshold.
Depth
Mitochondrial energy production is the strongest represented mechanism, with partial coverage in the saved findings.
Breadth
0 of the three mechanism targets meets the saved coverage threshold.

Evidence27

Coenzyme Q-10 leads the saved evidence comparison among ingredients meeting the amount threshold. This comparison does not imply uniform fatigue relief. The saved evidence match is incomplete for Coenzyme Q-10.
Evidence strength
Coenzyme Q-10 leads the saved evidence comparison among ingredients meeting the amount threshold. This comparison does not imply uniform fatigue relief.
Studied preparation
The saved evidence match is incomplete for Coenzyme Q-10.

Formulation logic100

The assessed ingredients work alone or have their required partner. No configured conflict was identified. 1 of 1 assessed ingredients meet the saved minimum amount threshold.
Partner coverage
The assessed ingredients work alone or have their required partner.
Conflicts
No configured conflict was identified.
Effective doses
1 of 1 assessed ingredients meet the saved minimum amount threshold.
Study evidence
Cardiovascular Support
Impact
Highest effect
A- Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 has limited support for changes in blood pressure, lipid or vessel-function markers in selected people with dyslipidemia. Its 100 mg per serving is below the 120 mg daily amount in the supplied trial. The saved findings accept its preparation, but the reader facts do not identify a form that establishes superiority or equivalent outcomes across preparations. Cardiovascular-event prevention is not established.

How this product is rated for Cardiovascular Support

Ingredient fit86

CoQ10 provides the cardiovascular-related focus, with links to several goals. The CoQ10 amount receives partial consideration.
Goal fit
CoQ10 provides the cardiovascular-related focus, with links to several goals.
Dose adequacy
The CoQ10 amount receives partial consideration.

Pathways53

Vessel-lining function is the principal represented route. Coverage is concentrated on this route.
Depth
Vessel-lining function is the principal represented route.
Breadth
Coverage is concentrated on this route.

Evidence88

CoQ10 supplies limited marker-based support in selected populations. The saved result accepts the preparation despite no form listed in the reader facts.
Evidence strength
CoQ10 supplies limited marker-based support in selected populations.
Studied preparation
The saved result accepts the preparation despite no form listed in the reader facts.

Formulation logic100

The amount-eligible ingredients have no missing required partner or listed ingredient conflict.
Partner coverage
The credited ingredients can contribute alone or have their required partner.
Conflicts
No listed ingredient conflict was found.
Effective doses
Every amount-eligible ingredient meets the inclusion criterion, without establishing a clinically effective dose.
Study evidence
Inflammation
Impact
High effect
C+ Ingredient FitF PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 supports antioxidant and mitochondrial processes. Its anti-inflammatory relevance comes from a small trial of ubiquinone in people with coronary artery disease taking statins: one inflammatory marker improved, while others did not. This provides limited biomarker support, without establishing routine clinical benefit. The 100 mg per serving is below the trial's 300 mg daily exposure.

How this product is rated for Inflammation

Ingredient fit66

CoQ10 provides a focused connection to the goal. CoQ10 receives partial amount recognition relative to the reviewed ubiquinone exposure.
Goal fit
CoQ10 provides a focused connection to the goal.
Dose adequacy
CoQ10 receives partial amount recognition relative to the reviewed ubiquinone exposure.

Pathways13

CoQ10 contributes mainly through oxidative stress. The saved contribution is limited within that route. Other inflammation routes are not meaningfully covered.
Depth
CoQ10 supplies the main oxidative-stress contribution, with limited depth at this amount.
Breadth
No route reaches the saved breadth threshold.

Evidence93

CoQ10 has relevant but qualified evidence. The saved findings accept the preparation, which does not establish routine clinical inflammation relief.
Evidence strength
CoQ10 evidence concerns selected biomarkers in statin-treated coronary artery disease, with other measured inflammatory markers unchanged.
Studied preparation
The saved finding accepts the relevant preparation; this does not remove the evidence's population and outcome limitations.

Formulation logic100

CoQ10 does not require an additional partner for its saved contribution. No configured ingredient conflict was identified, and the counted ingredients pass the saved amount threshold.
Partner coverage
The counted ingredients can contribute without an added partner; no required partner is missing.
Conflicts
No conflict was identified among the configured ingredients; unreviewed interactions remain outside this finding.
Effective doses
All counted ingredients pass the saved amount threshold, which is not proof of clinical effectiveness.
Study evidence
Metabolism Support
Impact
High effect
B- Ingredient FitF PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 helps transfer electrons in mitochondria as cells produce energy. This normal role and changes in metabolic-health markers do not establish a rise in whole-body energy expenditure. The 100 mg per serving makes a partial contribution in the saved amount comparison; it is not a proven metabolism-boosting dose.

How this product is rated for Metabolism Support

Ingredient fit73

CoQ10 is the sole included ingredient. The CoQ10 serving makes a partial contribution below the saved amount plateau.
Goal fit
CoQ10 is the sole included ingredient.
Dose adequacy
The CoQ10 serving makes a partial contribution below the saved amount plateau.

Pathways17

The strongest saved connection concerns mitochondrial energy and fat oxidation; this category does not establish extra calorie expenditure. No biological category meets the saved breadth comparison.
Depth
The strongest saved connection concerns mitochondrial energy and fat oxidation; this category does not establish extra calorie expenditure.
Breadth
No biological category meets the saved breadth comparison.

Evidence75

CoQ10 supplies the evidence connection, but mitochondrial function does not establish a whole-body metabolic-rate boost.
Evidence strength
CoQ10 supplies the evidence connection, but mitochondrial function does not establish a whole-body metabolic-rate boost.
Studied preparation
Eligible included preparations match the saved comparison; this does not establish product-specific thermogenesis.

Formulation logic100

No missing required partner or configured ingredient conflict was found.
Partner coverage
The included ingredients do not lack a required partner; this does not establish an added metabolism benefit from combining them.
Conflicts
No configured ingredient conflict was identified.
Effective doses
All included ingredients meet the saved minimum amount comparison, which is not a proven effective metabolism-boosting dose.
Study evidence

Ingredients

IngredientAmount per servingScore
Q-Sorb Coenzyme Q-10
100 mg 46
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
Coenzyme Q-10 · 100 mg OverallScore46
F Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyC Value
A serving lists 100 mg of CoQ10. The form is unknown in the saved facts, and a whole-product serving costs about $0.16.
How this ingredient is rated

Active Ingredient Quality & Bioavailability12

The CoQ10 form is unknown in the saved facts.
Molecular Form: Ubiquinol vs. Ubiquinone
The CoQ10 form is unknown in the saved facts, so a form-specific comparison is limited.
Formulation & Absorption Enhancers
The saved facts do not establish a named absorption-enhancing formulation or black pepper extract.

Dose, Safety & Label Transparency72

The label lists 100 mg CoQ10 per serving.
Clinical Dosage Alignment
The serving lists 100 mg CoQ10; the form is unknown.
Label Transparency & Fillers
The label lists 100 mg CoQ10 per serving; no flagged additives or standard fillers are recorded in the evaluated facts.

Value60

A whole-product serving costs about $0.16.
Price Per Effective Serving
The whole-product serving costs about $0.16.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10